Venus Medtech (Hangzhou) Inc. (HKG:2500)
1.210
-0.020 (-1.63%)
May 29, 2026, 4:08 PM HKT
Venus Medtech (Hangzhou) Revenue
In the year 2025, Venus Medtech (Hangzhou) had annual revenue of 306.79M CNY, down -34.84%. Venus Medtech (Hangzhou) had revenue of 119.65M in the half year ending December 31, 2025, a decrease of -49.25%.
Revenue
306.79M CNY
Revenue Growth
-34.84%
P/S Ratio
1.55
Revenue / Employee
547.83K CNY
Employees
560
Market Cap
529.86M HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 306.79M | -164.05M | -34.84% |
| Dec 31, 2024 | 470.83M | -20.54M | -4.18% |
| Dec 31, 2023 | 491.37M | 84.91M | 20.89% |
| Dec 31, 2022 | 406.46M | -9.40M | -2.26% |
| Dec 31, 2021 | 415.86M | 139.82M | 50.65% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sisram Medical | 2.84B |
| Austar Lifesciences | 1.70B |
| Yestar Healthcare Holdings Company | 1.66B |
| Gaush Meditech | 1.54B |
| Vincent Medical Holdings | 932.78M |
| Shanghai HeartCare Medical Technology Corporation | 454.34M |
| MicroPort CardioFlow Medtech | 444.00M |
| Suzhou Basecare Medical Corporation | 259.59M |
Venus Medtech (Hangzhou) News
- 2 months ago - Venus Medtech (Hangzhou) Earnings release: H2 2025 - Filings
- 2 months ago - Venus Medtech (Hangzhou) Annual report: H2 2025 - Filings
- 9 months ago - Venus Medtech (Hangzhou) Quarterly report: H1 2025 - Filings
- 9 months ago - Venus Medtech (Hangzhou) Earnings release: H1 2025 - Filings
- 1 year ago - Venus Medtech Reports 2024 Annual Results: Profitability Surges with Robust Global Expansion and Innovations - PRNewsWire
- 1 year ago - Venus Medtech (Hangzhou) Annual report: H2 2024 - Filings
- 1 year ago - Venus Medtech (Hangzhou) Earnings release: H2 2024 - Filings
- 1 year ago - Venus Medtech Venus-Vitae Completes First Two Implantations in SMART-ALIGN Pivotal Clinical Study - PRNewsWire